Humana Inc.

NYSE:HUM Stock Report

Market Cap: US$34.1b

Humana Past Earnings Performance

Past criteria checks 1/6

Humana's earnings have been declining at an average annual rate of -16.4%, while the Healthcare industry saw earnings growing at 3.1% annually. Revenues have been growing at an average rate of 10.9% per year. Humana's return on equity is 8.6%, and it has net margins of 1.3%.

Key information

-16.35%

Earnings growth rate

-14.48%

EPS growth rate

Healthcare Industry Growth8.50%
Revenue growth rate10.85%
Return on equity8.65%
Net Margin1.28%
Next Earnings Update05 Nov 2025

Recent past performance updates

Humana's (NYSE:HUM) Conservative Accounting Might Explain Soft Earnings

Feb 27
Humana's (NYSE:HUM) Conservative Accounting Might Explain Soft Earnings

Recent updates

Humana: Long-Term Recovery Potential, Short-Term Pressure

Oct 03

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

Aug 26
Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

Humana Inc. (NYSE:HUM) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Aug 15
Humana Inc. (NYSE:HUM) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Apr 30
Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Humana's (NYSE:HUM) Conservative Accounting Might Explain Soft Earnings

Feb 27
Humana's (NYSE:HUM) Conservative Accounting Might Explain Soft Earnings

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Feb 25
Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana Q4 Earnings Review: A Tough Quarter -- And A Rating Downgrade

Feb 12

Humana's Growth Vs. Rising Costs: Why It's A Hold For Cautious Investors

Jan 10

Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?

Dec 18

Humana: Medicare Advantage Is Just A Short-Term Problem

Dec 05

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Dec 02
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Nov 11
Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Humana - Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over

Nov 05

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Oct 28
Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Wall Street Lunch: Humana Shares Hit Hard

Oct 02

Humana's Falling Share Price Gives Investors An Opportunity

Sep 18

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Jul 24

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Jun 23

Humana Is Set Up For Long-Term Success

Jun 05

Humana: Where To Buy This

Apr 02

Humana: This Year's Drop Might Have Created A Buying Opportunity

Mar 19

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Feb 03

Humana: The $300 Level Could Get Taken Out In The Near Future

Jan 25

Humana: My Oh My, Another Strong Buy

Jan 14

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Jan 02

Humana: Failed Merger And Other Reasons To Buy

Dec 11

Revenue & Expenses Breakdown

How Humana makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:HUM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 25123,1101,57613,9640
31 Mar 25120,2621,71013,5580
31 Dec 24117,7611,20713,2150
30 Sep 24115,0101,35912,8010
30 Jun 24112,0361,71112,5940
31 Mar 24109,2431,99112,6250
31 Dec 23106,3742,48912,5910
30 Sep 23102,3513,01512,5670
30 Jun 2398,7273,37812,4320
31 Mar 2395,6423,11512,2910
31 Dec 2292,8702,80612,1980
30 Sep 2291,4852,80712,2300
30 Jun 2290,5123,14311,8540
31 Mar 2287,4953,03511,0000
31 Dec 2183,0642,93310,1210
30 Sep 2182,2012,6739,7940
30 Jun 2180,4502,4829,7040
31 Mar 2178,8883,7229,9420
31 Dec 2077,1553,36710,0520
30 Sep 2074,3884,1539,0660
30 Jun 2070,5543,5028,4420
31 Mar 2067,7162,6147,7910
31 Dec 1964,8882,7077,3810
30 Sep 1962,7612,5507,3670
30 Jun 1960,7262,5057,3780
31 Mar 1958,7401,7587,4360
31 Dec 1856,9121,6837,5250
30 Sep 1855,9331,5127,1350
30 Jun 1855,0091,3676,9230
31 Mar 1854,2841,8246,6150
31 Dec 1753,7672,4486,4190
30 Sep 1753,4561,8636,6950
30 Jun 1753,8681,8146,7460
31 Mar 1754,3411,4756,9920
31 Dec 1654,3796147,1730
30 Sep 1654,8621,1167,0280
30 Jun 1654,5319806,9660
31 Mar 1654,2561,1007,0840
31 Dec 1554,2891,2767,2950
30 Sep 1553,2561,3207,5600
30 Jun 1552,1311,2967,7810
31 Mar 1550,6211,2097,7990
31 Dec 1448,5001,1477,6390

Quality Earnings: HUM has high quality earnings.

Growing Profit Margin: HUM's current net profit margins (1.3%) are lower than last year (1.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HUM's earnings have declined by 16.4% per year over the past 5 years.

Accelerating Growth: HUM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: HUM had negative earnings growth (-7.9%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).

Return on Equity

High ROE: HUM's Return on Equity (8.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/06 04:17
End of Day Share Price 2025/10/06 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Humana Inc. is covered by 48 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Hua HaBaird
Joshua RaskinBarclays